117 related articles for article (PubMed ID: 38940542)
1. Characterization of mAbs against
Berry SK; Rust S; Irving L; Bartholdson Scott J; Weinert LA; Dougan G; Christie G; Warrener P; Minter R; Grant AJ
Microbiol Spectr; 2024 Jun; ():e0040024. PubMed ID: 38940542
[TBL] [Abstract][Full Text] [Related]
2. Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit.
Wang Q; Chang CS; Pennini M; Pelletier M; Rajan S; Zha J; Chen Y; Cvitkovic R; Sadowska A; Heidbrink Thompson J; Yu Lin H; Barnes A; Rickert K; Wilson S; Stover CK; Dall'Acqua WF; Chowdhury PS; Xiao X
J Infect Dis; 2016 Jun; 213(11):1800-8. PubMed ID: 26768253
[TBL] [Abstract][Full Text] [Related]
3. A protein containing the DUF1471 domain regulates biofilm formation and capsule production in Klebsiella pneumoniae.
Horng YT; Dewi Panjaitan NS; Chang HJ; Wei YH; Chien CC; Yang HC; Chang HY; Soo PC
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1246-1254. PubMed ID: 34924339
[TBL] [Abstract][Full Text] [Related]
4. Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation.
Langstraat J; Bohse M; Clegg S
Infect Immun; 2001 Sep; 69(9):5805-12. PubMed ID: 11500458
[TBL] [Abstract][Full Text] [Related]
5. Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA.
Wang Q; Chen Y; Cvitkovic R; Pennini ME; Chang CS; Pelletier M; Bonnell J; Koksal AC; Wu H; Dall'Acqua WF; Stover CK; Xiao X
PLoS One; 2017; 12(1):e0170529. PubMed ID: 28107434
[TBL] [Abstract][Full Text] [Related]
6. Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection.
Diago-Navarro E; Motley MP; Ruiz-Peréz G; Yu W; Austin J; Seco BMS; Xiao G; Chikhalya A; Seeberger PH; Fries BC
mBio; 2018 Apr; 9(2):. PubMed ID: 29615497
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic whole-cell screening identifies a protective carbohydrate epitope on
Berry SK; Rust S; Caceres C; Irving L; Bartholdson Scott J; Tabor DE; Dougan G; Christie G; Warrener P; Minter R; Grant AJ
MAbs; 2022; 14(1):2006123. PubMed ID: 34923908
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones.
Gual-de-Torrella A; Delgado-Valverde M; Pérez-Palacios P; Oteo-Iglesias J; Rojo-Molinero E; Macià MD; Oliver A; Pascual Á; Fernández-Cuenca F
Int J Antimicrob Agents; 2022 Oct; 60(4):106663. PubMed ID: 35995073
[TBL] [Abstract][Full Text] [Related]
9. EtcABC, a Putative EII Complex, Regulates Type 3 Fimbriae via CRP-cAMP Signaling in
Panjaitan NSD; Horng YT; Cheng SW; Chung WT; Soo PC
Front Microbiol; 2019; 10():1558. PubMed ID: 31354661
[TBL] [Abstract][Full Text] [Related]
10. Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation.
Alcántar-Curiel MD; Blackburn D; Saldaña Z; Gayosso-Vázquez C; Iovine NM; De la Cruz MA; Girón JA
Virulence; 2013 Feb; 4(2):129-38. PubMed ID: 23302788
[TBL] [Abstract][Full Text] [Related]
11. MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression.
Wilksch JJ; Yang J; Clements A; Gabbe JL; Short KR; Cao H; Cavaliere R; James CE; Whitchurch CB; Schembri MA; Chuah ML; Liang ZX; Wijburg OL; Jenney AW; Lithgow T; Strugnell RA
PLoS Pathog; 2011 Aug; 7(8):e1002204. PubMed ID: 21901098
[TBL] [Abstract][Full Text] [Related]
12. Difference in biofilm formation between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae based on analysis of mrkH distribution.
Fang R; Liu H; Zhang X; Dong G; Li J; Tian X; Wu Z; Zhou J; Cao J; Zhou T
Microb Pathog; 2021 Mar; 152():104743. PubMed ID: 33484812
[TBL] [Abstract][Full Text] [Related]
13. The role of EII complex in the bacterial responses to the glucose-survey in clinical Klebsiella pneumoniae isolates.
Horng YT; Panjaitan NSD; Tsai YJ; Su PW; Yang HC; Soo PC
PLoS One; 2023; 18(8):e0289759. PubMed ID: 37549172
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein.
Yang J; Wilksch JJ; Tan JW; Hocking DM; Webb CT; Lithgow T; Robins-Browne RM; Strugnell RA
PLoS One; 2013; 8(11):e79038. PubMed ID: 24244411
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated OmpR Is Required for Type 3 Fimbriae Expression in
Lin TH; Chen Y; Kuo JT; Lai YC; Wu CC; Huang CF; Lin CT
Front Microbiol; 2018; 9():2405. PubMed ID: 30369914
[TBL] [Abstract][Full Text] [Related]
16. MrkF is a component of type 3 fimbriae in Klebsiella pneumoniae.
Huang YJ; Liao HW; Wu CC; Peng HL
Res Microbiol; 2009; 160(1):71-9. PubMed ID: 19028568
[TBL] [Abstract][Full Text] [Related]
17. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation.
Schroll C; Barken KB; Krogfelt KA; Struve C
BMC Microbiol; 2010 Jun; 10():179. PubMed ID: 20573190
[TBL] [Abstract][Full Text] [Related]
18. Adherence properties of an mrkD-negative mutant of Klebsiella pneumoniae.
Hornick DB; Thommandru J; Smits W; Clegg S
Infect Immun; 1995 May; 63(5):2026-32. PubMed ID: 7729917
[TBL] [Abstract][Full Text] [Related]
19. Identification of protein domains on major pilin MrkA that affects the mechanical properties of Klebsiella pneumoniae type 3 fimbriae.
Chan CH; Chen FJ; Huang YJ; Chen SY; Liu KL; Wang ZC; Peng HL; Yew TR; Liu CH; Liou GG; Hsu KY; Chang HY; Hsu L
Langmuir; 2012 May; 28(19):7428-35. PubMed ID: 22524463
[TBL] [Abstract][Full Text] [Related]
20. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
Motley MP; Diago-Navarro E; Banerjee K; Inzerillo S; Fries BC
mBio; 2020 Sep; 11(5):. PubMed ID: 32900809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
